Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis-Reference-Cited by-同舟云学术

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

Published:2009-02 Issue:2 Volume:60 Page:335-344
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Cohen Stanley B.,Cheng Tien-Tsai,Chindalore Vishala,Damjanov Nemanja,Burgos-Vargas Ruben,DeLora Patricia,Zimany Kathleen,Travers Helen,Caulfield John P.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference28 articles.

1. Pathway to the clinic: inhibition of p38 MAP kinase. A review of ten chemotypes selected for development;Goldstein;Curr Top Med Chem,2005

2. Novel pathways that regulate tumor necrosis factor-α production in rheumatoid arthritis;Gracie;Curr Opin Rheumatol,2002

3. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases;Salituro;Curr Med Chem,1999

4. p38 MAPK signalling cascades in inflammatory disease;Herlaar;Mol Med Today,1999

5. Induction of cyclooxygenase-2 by the activated MEKK1→ SEK1/MKK4→p38 mitogen-activated protein kinase pathway;Guan;J Biol Chem,1998

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The KINETIC phase 2 randomized controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients;iScience;2023-10

2. Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i);Pharmaceuticals;2023-09-12

3. Antioxidant and Antineuroinflammatory Mechanisms of Kaempferol-3-O-β-d-Glucuronate on Lipopolysaccharide-Stimulated BV2 Microglial Cells through the Nrf2/HO-1 Signaling Cascade and MAPK/NF-κB Pathway;ACS Omega;2023-02-10

4. Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis;ACR Open Rheumatology;2023-01-05

5. The American Society of Pain and Neuroscience (ASPN) Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain;Journal of Pain Research;2022-12